Capricor Therapeutics
CAPR
#4976
Rank
C$2.30 B
Marketcap
C$40.15
Share price
-3.51%
Change (1 day)
143.98%
Change (1 year)

Capricor Therapeutics (CAPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$59.13 Million

According to Capricor Therapeutics 's latest financial reports the company's total liabilities are C$59.13 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$35.9 M-25.09%
2023-12-31C$47.92 M-7.81%
2022-12-31C$51.98 M309.43%
2021-12-31C$12.69 M55.12%
2020-12-31C$8.18 M46.62%
2019-12-31C$5.58 M-11.52%
2018-12-31C$6.3 M-0.57%
2017-12-31C$6.34 M-79.25%
2016-12-31C$30.57 M28.88%
2015-12-31C$23.72 M2.82%
2014-12-31C$23.07 M256.89%
2013-12-31C$6.46 M1128.51%
2012-12-31C$0.52 M-4.46%
2011-12-31C$0.55 M-48.46%
2010-12-31C$1.06 M59.3%
2009-12-31C$0.67 M-58.58%
2008-12-31C$1.61 M-14.08%
2007-12-31C$1.88 M1101.15%
2006-12-31C$0.15 M73.01%
2005-12-31C$0.09 M27.13%
2004-12-31C$0.07 M31.68%
2003-12-31C$0.05 M39.7%
2002-12-31C$0.03 M165.04%
2001-12-31C$0.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$163.46 B 276,299.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.91 B 3,137.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$2.89 B 4,795.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$77.54 M 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$11.41 M-80.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$3.61 M-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA